Healthequity Inc

HQY remains in a Stage 2 advancing uptrend backed by clear higher highs and higher lows above the rising EMAs and 50 DMA. The primary Devil’s Bargain pattern signals sustained buying pressure, but price is extended above the 9/20 EMA zone and RSI and Options Score are in extreme overbought territory, making immediate entry suboptimal. Execution is deferred: await a pullback and acceptance into the rising 9/20 EMA area for a higher-probability bullish engagement.

• ↑Q1 2027 revenue reached $297.2M (+7% YoY) with adjusted EBITDA of $164.5M (46% margin).
• ↑Working Families Tax Cut Act expands HSA eligibility by 3–4M American families.
• ↓Low profitability metrics indicate challenges converting revenue into net income.